CD4 and pneumonia: The MXF-19 complex ((o-Fph)PPhβCD) demonstrated immunomodulatory effects both in metal-induced aseptic inflammation and in the acute pneumonia model, leading to normalization of CD4+ and CD4+CD25+ populations and a reduction in CD4+CD25+FoxP3+ T cells [24,25].